Literature DB >> 12849150

The use of quantitative magnetic-resonance-based techniques to monitor the evolution of multiple sclerosis.

Massimo Filippi1, Maria A Rocca, Giancarlo Comi.   

Abstract

Conventional MRI can improve accuracy in the diagnosis of multiple sclerosis (MS) and monitor the efficacy of experimental treatments. However, conventional MRI provides only gross estimates of the extent and nature of tissue damage associated with this disease. Other quantitative magnetic-resonance-based techniques have the potential to overcome the limitations of conventional MRI and, as a consequence, to improve our understanding of the natural history of MS. Magnetisation-transfer, diffusion-weighted, and functional MRI--as well as proton magnetic-resonance spectroscopy--are helping us to elucidate the mechanisms that underlie injury, repair, and functional adaptation in patients with MS. These techniques are substantially changing our understanding of how MS causes irreversible disability and should be used more extensively in clinical trials and in studies of disease progression.

Entities:  

Mesh:

Year:  2003        PMID: 12849150     DOI: 10.1016/s1474-4422(03)00408-3

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  14 in total

1.  A novel PET marker for in vivo quantification of myelination.

Authors:  Chunying Wu; Changning Wang; Daniela C Popescu; Wenxia Zhu; Eduardo A Somoza; Junqing Zhu; Allison G Condie; Christopher A Flask; Robert H Miller; Wendy Macklin; Yanming Wang
Journal:  Bioorg Med Chem       Date:  2010-11-09       Impact factor: 3.641

2.  MRI quantification of gray and white matter damage in patients with early-onset multiple sclerosis.

Authors:  P Tortorella; M A Rocca; D M Mezzapesa; A Ghezzi; L Lamantia; G Comi; M Filippi
Journal:  J Neurol       Date:  2006-03-06       Impact factor: 4.849

3.  Diffusion-weighted MR imaging characteristics of an acute strokelike form of multiple sclerosis.

Authors:  C Rosso; P Remy; A Creange; P Brugieres; P Cesaro; H Hosseini
Journal:  AJNR Am J Neuroradiol       Date:  2006-05       Impact factor: 3.825

4.  Magnetization transfer imaging in premanifest and manifest Huntington disease.

Authors:  S J A van den Bogaard; E M Dumas; J Milles; R Reilmann; J C Stout; D Craufurd; M A van Buchem; J van der Grond; R A C Roos
Journal:  AJNR Am J Neuroradiol       Date:  2012-01-12       Impact factor: 3.825

5.  Effects of glatiramer acetate and interferon-beta on neurodegeneration in a model of multiple sclerosis: a comparative study.

Authors:  Katharina Maier; Antje V Kuhnert; Naimeh Taheri; Muriel B Sättler; Maria K Storch; Sarah K Williams; Mathias Bähr; Ricarda Diem
Journal:  Am J Pathol       Date:  2006-10       Impact factor: 4.307

6.  Reproducibility over a 1-month period of 1H-MR spectroscopic imaging NAA/Cr ratios in clinically stable multiple sclerosis patients.

Authors:  J P Mostert; Y Blaauw; M W Koch; A J Kuiper; J M Hoogduin; J De Keyser
Journal:  Eur Radiol       Date:  2008-04-04       Impact factor: 5.315

7.  Diffusion-weighted imaging of normal appearing corticospinal tracts in patients with multiple sclerosis.

Authors:  Kadihan Yalçın-Şafak; Ahmet Akça; Özlem Elibol; İrem Sarı
Journal:  Neuroradiol J       Date:  2017-12-20

8.  Magnetization transfer imaging in premanifest and manifest huntington disease: a 2-year follow-up.

Authors:  S J A van den Bogaard; E M Dumas; E P Hart; J Milles; R Reilmann; J C Stout; D Craufurd; C R Gibbard; S J Tabrizi; M A van Buchem; J van der Grond; R A C Roos
Journal:  AJNR Am J Neuroradiol       Date:  2012-08-23       Impact factor: 3.825

9.  Diffusion tensor MR imaging of the cervical spinal cord in patients with multiple sclerosis.

Authors:  Yoshimitsu Ohgiya; Masaki Oka; Akio Hiwatashi; Xiang Liu; Naoya Kakimoto; Per-Lennart A Westesson; Sven E Ekholm
Journal:  Eur Radiol       Date:  2007-05-16       Impact factor: 5.315

10.  Magnetization transfer imaging in 'premanifest' Huntington's disease.

Authors:  Caroline K Jurgens; Reineke Bos; Jasper Luyendijk; Marie-Noëlle W Witjes-Ané; Jeroen van der Grond; Huub A M Middelkoop; Raymund A C Roos
Journal:  J Neurol       Date:  2009-10-13       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.